Homeland Uranium Inc.

Homeland Uranium Inc.

November 27, 2009 17:30 ET

Homeland Uranium Inc. Reprices Options

TORONTO, ONTARIO--(Marketwire - Nov. 27, 2009) - Homeland Uranium Inc., ("Homeland" or the "Company") announced that it has re-priced options to purchase 2,005,000 common shares expiring on May 7, 2012 from $0.50 to $0.25. These options are held by directors, officers and employees of the Company.

The Company also announced that it has re-priced options to purchase 2,085,000 common shares expiring on March 6, 2013 from $0.80 to $0.25. These options are held by directors, officers and employees of the Company.

The Company further announced that it has re-priced options to purchase 100,000 common shares expiring on November 21, 2013 from $0.80 to $0.25. These options are held by employees of the Company.

The re-pricing has been approved by the Compensation Committee of the Company.

Homeland

The Company is a natural resource company engaged in the acquisition, exploration and development of uranium properties. The Company's focus is on exploration for uranium in the Arlit region of Niger, where the Company has an interest in the Agelal Project and the Asekra Project, which include eight exploration concessions covering an area of approximately 3,731 square kilometres within the Tim-Merso? Basin. The Company also holds rights to exploration properties in Colorado and Utah, United States. Homeland owns approximately 23.9% of the issued and outstanding common shares of Macusani Yellowcake (TSX VENTURE:YEL) on a non-diluted basis. Macusani Yellowcake is developing an advanced stage uranium project in Macusani Plateau region of Peru.

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

Contact Information